eFFECTOR Therapeutics Stock Price, News & Analysis
LWACU
NASDAQ
Company Description
Welcome to the overview page for eFFECTOR Therapeutics (LWACU), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
Latest News
SEC Filings
Financial Highlights
$47,186
Net Income (TTM)
$0.01
$10,409
Operating Cash Flow
0.08
$47,186
—
Revenue (TTM)
Upcoming Events
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of eFFECTOR Therapeutics (LWACU)?
The current stock price of eFFECTOR Therapeutics (LWACU) is $10.0823 as of October 14, 2025.
What is the net income of eFFECTOR Therapeutics (LWACU)?
The trailing twelve months (TTM) net income of eFFECTOR Therapeutics (LWACU) is $47,186.
What is the earnings per share (EPS) of eFFECTOR Therapeutics (LWACU)?
The diluted earnings per share (EPS) of eFFECTOR Therapeutics (LWACU) is $0.01 on a trailing twelve months (TTM) basis. Learn more about EPS .
What is the operating cash flow of eFFECTOR Therapeutics (LWACU)?
The operating cash flow of eFFECTOR Therapeutics (LWACU) is $10,409. Learn about cash flow.
What is the current ratio of eFFECTOR Therapeutics (LWACU)?
The current ratio of eFFECTOR Therapeutics (LWACU) is 0.08, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the operating income of eFFECTOR Therapeutics (LWACU)?
The operating income of eFFECTOR Therapeutics (LWACU) is $47,186. Learn about operating income.